Brent Rupnow

1.1k total citations
19 papers, 658 citations indexed

About

Brent Rupnow is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Brent Rupnow has authored 19 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Brent Rupnow's work include Prostate Cancer Treatment and Research (5 papers), Cancer-related Molecular Pathways (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Brent Rupnow is often cited by papers focused on Prostate Cancer Treatment and Research (5 papers), Cancer-related Molecular Pathways (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Brent Rupnow collaborates with scholars based in United States, Switzerland and Belgium. Brent Rupnow's co-authors include Susan J. Knox, Amato J. Giaccia, Rodolfo Alarcón, Albert Murtha, Malavi T. Madireddi, Joseph Fargnoli, Wen-Pin Yang, Tai W. Wong, Urvashi V. Roongta and Rolf-Peter Ryseck and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Brent Rupnow

18 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brent Rupnow United States 10 353 235 180 64 63 19 658
Hassan Hall United States 11 954 2.7× 224 1.0× 155 0.9× 38 0.6× 32 0.5× 11 1.1k
Russell Bandle United States 14 855 2.4× 106 0.5× 125 0.7× 29 0.5× 39 0.6× 18 1.1k
Marilyn L. Keeler United States 7 839 2.4× 69 0.3× 199 1.1× 43 0.7× 75 1.2× 7 1.1k
Fang Guo China 8 762 2.2× 580 2.5× 146 0.8× 51 0.8× 47 0.7× 23 1.0k
Lakshmi Reddy Bollu United States 15 565 1.6× 319 1.4× 233 1.3× 154 2.4× 44 0.7× 24 930
Phuong Nguyen United States 7 532 1.5× 354 1.5× 159 0.9× 129 2.0× 34 0.5× 10 728
KangAe Lee United States 6 444 1.3× 391 1.7× 175 1.0× 73 1.1× 80 1.3× 6 832
Yehenew M. Agazie United States 19 1.0k 2.9× 102 0.4× 281 1.6× 51 0.8× 41 0.7× 31 1.2k
Renata Windak Poland 6 413 1.2× 164 0.7× 69 0.4× 30 0.5× 50 0.8× 18 689
Bhaswati Sarcar United States 12 418 1.2× 201 0.9× 142 0.8× 67 1.0× 17 0.3× 19 675

Countries citing papers authored by Brent Rupnow

Since Specialization
Citations

This map shows the geographic impact of Brent Rupnow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brent Rupnow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brent Rupnow more than expected).

Fields of papers citing papers by Brent Rupnow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brent Rupnow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brent Rupnow. The network helps show where Brent Rupnow may publish in the future.

Co-authorship network of co-authors of Brent Rupnow

This figure shows the co-authorship network connecting the top 25 collaborators of Brent Rupnow. A scholar is included among the top collaborators of Brent Rupnow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brent Rupnow. Brent Rupnow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jayaram, Anuradha, Nicholas A. Zorko, Kevin Zarrabi, et al.. (2026). A phase 1, first-in-human, dose escalation study of JNJ-80038114, a PSMAxCD3 bispecific antibody, in participants with metastatic castration-resistant prostate cancer. Cancer Chemotherapy and Pharmacology. 96(1). 5–5.
2.
Shen, Fei, William Kevin Kelly, Neeta Pandit‐Taskar, et al.. (2024). Preclinical characterization of human Kallikrein 2 (hK2) as a novel target for the treatment of prostate cancer.. Journal of Clinical Oncology. 42(4_suppl). 202–202. 2 indexed citations
3.
Lercher, Lukas, Nina Simon, Andreas Bergmann, et al.. (2022). Identification of Two Non-Peptidergic Small Molecule Inhibitors of CBX2 Binding to K27 Trimethylated Oligonucleosomes. SLAS DISCOVERY. 27(5). 306–313. 5 indexed citations
4.
Basu, Subhasree, Mike R. Russell, Katrin Sproesser, et al.. (2022). Abstract LB087: Characterization of JNJ-70218902, a TMEFF2 x CD3 bispecific antibody, in prostate cancer models. Cancer Research. 82(12_Supplement). LB087–LB087. 1 indexed citations
5.
Zhang, Zhuming, et al.. (2020). AKR1C3 mediates pan‐AR antagonist resistance in castration‐resistant prostate cancer. The Prostate. 80(14). 1223–1232. 4 indexed citations
6.
Horn, Leora, Martin Reck, Scott Gettinger, et al.. (2016). CheckMate 331: An open-label, randomized phase III trial of nivolumab versus chemotherapy in patients (pts) with relapsed small cell lung cancer (SCLC) after first-line platinum-based chemotherapy (PT-DC).. Journal of Clinical Oncology. 34(15_suppl). TPS8578–TPS8578. 21 indexed citations
7.
Roongta, Urvashi V., Jonathan G. Pabalan, Xinyu Wang, et al.. (2011). Cancer Cell Dependence on Unsaturated Fatty Acids Implicates Stearoyl-CoA Desaturase as a Target for Cancer Therapy. Molecular Cancer Research. 9(11). 1551–1561. 209 indexed citations
8.
Roongta, Urvashi V., R. Michael Lawrence, Tai W. Wong, et al.. (2011). Abstract C62: Cancer cell dependence on unsaturated fatty acids implicates stearoyl-coA desaturase as a target for cancer therapy. Cancer Research. 71(18_Supplement). C62–C62. 2 indexed citations
9.
Gavai, Ashvinikumar V., Derek Norris, George L. Trainor, et al.. (2008). 290 POSTER Pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Aurora kinases. European Journal of Cancer Supplements. 6(12). 93–94. 1 indexed citations
10.
Murtha, Albert, Susan J. Knox, Richard T. Hoppe, Brent Rupnow, & John Hanson. (2001). Long-term follow-up of patients with Stage III follicular lymphoma treated with primary radiotherapy at Stanford University. International Journal of Radiation Oncology*Biology*Physics. 49(1). 3–15. 29 indexed citations
11.
Rupnow, Brent & Susan J. Knox. (1999). The role of radiation-induced apoptosis as a determinant of tumor responses to radiation therapy. APOPTOSIS. 4(2). 115–143. 77 indexed citations
12.
Rupnow, Brent, Albert Murtha, Eric Chen, & Susan J. Knox. (1998). Myc activation reduces fibroblast clonogenicity via an apoptotic mechanism that can be suppressed by a soluble paracrine factor. Cancer Letters. 127(1-2). 211–219. 13 indexed citations
13.
Rupnow, Brent, Rodolfo Alarcón, Amato J. Giaccia, & Susan J. Knox. (1998). p53 mediates apoptosis induced by c-Myc activation in hypoxic or gamma irradiated fibroblasts. Cell Death and Differentiation. 5(2). 141–147. 30 indexed citations
14.
Rupnow, Brent, Albert Murtha, Rodolfo Alarcón, Amato J. Giaccia, & Susan J. Knox. (1998). Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy.. PubMed. 58(9). 1779–84. 73 indexed citations
15.
Murtha, Albert, et al.. (1997). 2004 Low dose rate radiation favors apoptosis as a mechanism of cell death. International Journal of Radiation Oncology*Biology*Physics. 39(2). 242–242. 2 indexed citations
16.
Rupnow, Brent, et al.. (1996). Association of BCL-2 with membrane hyperpolarization and radioresistance. Journal of Cellular Physiology. 168(1). 114–122. 40 indexed citations
17.
Rupnow, Brent, et al.. (1996). Over-expression of Bcl-2 protects against apoptosis induced by the bioreductive cytotoxic drug SR4233 (Tirapazamine).. PubMed. 3(2). 215–22. 4 indexed citations
18.
Alarcón, Rodolfo, Brent Rupnow, Thomas G. Graeber, Susan J. Knox, & Amato J. Giaccia. (1996). Modulation of c-Myc activity and apoptosis in vivo.. PubMed. 56(19). 4315–9. 79 indexed citations
19.
Rupnow, Brent, et al.. (1992). Fundulus heteroclitus gonadotropins. 3. Cloning and sequencing of gonadotropic hormone (GTH) I and II β-subunits using the polymerase chain reaction. Molecular and Cellular Endocrinology. 85(1-2). 127–139. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hassan Hall Breakdown of academic impact, for papers by Russell Bandle Breakdown of academic impact, for papers by Marilyn L. Keeler Breakdown of academic impact, for papers by Fang Guo Breakdown of academic impact, for papers by Lakshmi Reddy Bollu Breakdown of academic impact, for papers by Phuong Nguyen Breakdown of academic impact, for papers by KangAe Lee Breakdown of academic impact, for papers by Yehenew M. Agazie Breakdown of academic impact, for papers by Renata Windak Breakdown of academic impact, for papers by Bhaswati Sarcar
Rankless by CCL
2026